BLOOD PRODUCTS – AUSTRALIA

Gloomy growth forecast bloodies bullish CSL investors

roymorgansocial Leave a comment

Original article by Jessica Gardner
The Australian Financial Review – Page: 21 & 26 : 12-Feb-15

Australian-listed CSL has posted a 2014-15 interim net profit of $US692.2m, which is 7.2 per cent higher than previously. Revenue for the half-year was $A2.8bn, an increase of 5.6 per cent. CSL has advised that its full-year profit will be below previous guidance, although it is still on track to deliver a double-digit increase in earning. Shareholders will receive a half-year dividend of $US0.58 per share

CORPORATES
CSL LIMITED – ASX CSL, UBS HOLDINGS PTY LTD, PHILO CAPITAL ADVISERS PTY LTD, UNITED STATES. FOOD AND DRUG ADMINISTRATION, AURORA FUNDS MANAGEMENT LIMITED, STANDARD AND POOR’S ASX 200 INDEX

CBA, CSL and Macquarie Group on track for $100 shares

roymorgansocial Leave a comment

Original article by Simon Evans
The Australian Financial Review – Page: 22 : 22-Jan-15

Shares in CSL and the Commonwealth Bank are currently trading at about $A84. While they have recently retreated from 12-months peaks, both stocks could potentially rise to $A100. CSL previously undertook a share split after its stock rose to $A100 in late 2007. Arnhem Investment Management’s George Clapham suggests that in many cases a demerger rather than a share split may generate more value for shareholders. Macquarie Group’s shares are currently trading above $A60, and the stock is also a potential candidate to breach $A100

CORPORATES
CSL LIMITED – ASX CSL, COMMONWEALTH BANK OF AUSTRALIA – ASX CBA, MACQUARIE GROUP LIMITED – ASX MQG, ARNHEM INVESTMENT MANAGEMENT PTY LTD, AMCOR LIMITED – ASX AMC, ORORA LIMITED – ASX ORA, BRAMBLES LIMITED – ASX BXB, RECALL HOLDINGS LIMITED – ASX REC, IRON MOUNTAIN INCORPORATED, ELDERS LIMITED – ASX ELD, BERKSHIRE HATHAWAY INCORPORATED